J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price ...

Elon Musk and Mark Cuban rallied memesters and then voters, traders made big bets, and young men played key roles in both ...

Apple shares were the laggard over the past two trading days, while Tesla and Google stood out as stock market gainers.

Co-Diagnostics ( (CODX) ) has released its Q3 earnings. Here is a breakdown of the information Co-Diagnostics presented to its investors.

Liveperson ( (LPSN) ) has released its Q3 earnings. Here is a breakdown of the information Liveperson presented to its investors. LivePerson, ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on RCKT stock, giving a Buy rating today. Tyler Van Buren has given his ...

William Blair analyst Sami Corwin has maintained their bullish stance on RCKT stock, giving a Buy rating yesterday. Sami Corwin has given his ...

The event brought together representatives from business, the scientific and engineering communities ... the exchange of ...

Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm’s clinical program is a LVV-based gene therapy for ...

Cory Jubinville, PhD, an analyst from LifeSci Capital, maintained the Buy rating on Rocket Pharmaceuticals (RCKT – Research Report). The ...

IMUNON (IMNN) announced the presentation of new clinical data from the recently completed Phase 2 OVATION 2 Study of IMNN-001, its ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...